IRIS UniCatt

Orlandi, Armando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.433
EU - Europa 1.978
AS - Asia 978
SA - Sud America 202
AF - Africa 51
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.650
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.400
DE - Germania 515
SE - Svezia 437
SG - Singapore 349
CN - Cina 291
IT - Italia 279
BR - Brasile 190
FR - Francia 122
IE - Irlanda 121
IN - India 112
PL - Polonia 111
GB - Regno Unito 83
ID - Indonesia 70
FI - Finlandia 68
RU - Federazione Russa 60
UA - Ucraina 51
CI - Costa d'Avorio 38
HK - Hong Kong 34
KR - Corea 27
TR - Turchia 25
CA - Canada 22
AT - Austria 18
BE - Belgio 18
IR - Iran 16
VN - Vietnam 15
ES - Italia 13
RO - Romania 13
LT - Lituania 11
NL - Olanda 11
CH - Svizzera 10
JP - Giappone 10
CZ - Repubblica Ceca 9
MX - Messico 8
MA - Marocco 7
LU - Lussemburgo 6
BD - Bangladesh 5
EC - Ecuador 5
RS - Serbia 5
AU - Australia 4
NO - Norvegia 4
SA - Arabia Saudita 4
AR - Argentina 3
GE - Georgia 3
IQ - Iraq 3
LV - Lettonia 3
PK - Pakistan 3
CO - Colombia 2
EG - Egitto 2
EU - Europa 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
TN - Tunisia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
DK - Danimarca 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VE - Venezuela 1
Totale 5.650
Salva come PNG Salva come JPEG
Città #
Chandler 487
Singapore 241
Ashburn 208
Dublin 115
Warsaw 107
New York 94
Hyderabad 87
Fairfield 78
Chicago 73
Jakarta 69
Wilmington 69
Rome 68
The Dalles 68
Houston 64
San Mateo 64
Boston 49
Ann Arbor 48
Princeton 47
Woodbridge 47
Moscow 43
Los Angeles 41
Nanjing 40
Milan 39
Abidjan 38
Munich 37
Seattle 37
Helsinki 36
Cattolica 34
Hefei 33
Jacksonville 33
Cambridge 32
Dearborn 29
Frankfurt am Main 29
Hong Kong 28
Redwood City 28
London 26
Marseille 26
Seoul 26
Beijing 21
Izmir 21
Nürnberg 21
Nuremberg 20
Düsseldorf 18
Bremen 16
Brussels 16
Turku 16
Nanchang 14
Toronto 13
Buffalo 12
Lawrence 12
São Paulo 12
Boardman 11
Salt Lake City 11
Hangzhou 10
Lauterbourg 10
Mountain View 10
Fremont 9
Lancaster 9
San Diego 9
Washington 9
Andover 8
Augusta 8
Dong Ket 8
North Bergen 8
Norwalk 8
Guangzhou 7
Madrid 7
Pescara 7
Tampa 7
Bari 6
Berlin 6
Elk Grove Village 6
Falls Church 6
Hebei 6
Kish 6
Leawood 6
Mexico City 6
Paris 6
Pune 6
Shenyang 6
Vienna 6
Amsterdam 5
Belgrade 5
Belo Horizonte 5
Bucharest 5
Busto Arsizio 5
Caxias do Sul 5
Cluj-Napoca 5
Millbury 5
Ottawa 5
San Francisco 5
Santa Clara 5
Sterling 5
Zurich 5
Caserta 4
Changsha 4
Clearwater 4
Detroit 4
Dulles 4
Ho Chi Minh City 4
Totale 3.247
Salva come PNG Salva come JPEG
Nome #
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 260
Neoadjuvant chemotherapy in breast cancer: An advanced personalized multidisciplinary prehabilitation model (apmp-m) to optimize outcomes 232
Diagnosis and management of breast lymphoma: A single-institution retrospective analysis 195
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 190
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 171
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 162
Mastectomy in precision oncology era: Myth or reality? 149
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 128
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 118
AMAROS Study: Overall Survival in Breast Cancer Subtypes 117
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 116
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 113
Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report 112
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 107
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 96
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 95
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 90
Paradox CA 15-3 increase in metastatic breast cancer patients treated with everolimus: A change of paradigm in a case series 88
Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer: Preliminary experience with clinically node negative patients after systemic treatment 88
Menopausal hormone therapy: What should be kept in mind for a personalized choice in a shared decision-making 87
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 85
Immediate prosthetic breast reconstruction after nipple-sparing mastectomy: Traditional subpectoral technique versus direct-to-implant prepectoral reconstruction without acellular dermal matrix 83
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas 82
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 81
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 81
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 79
Let‐7a‐5p, mir‐100‐5p, mir‐101‐3p, and mir‐199a‐3p hyperexpression as potential predictive biomarkers in early breast cancer patients 79
A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer 79
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies 78
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 77
OlympiAD trial: moving to a next level of treatment for patients with BRCA mutation and her2-negative metastatic breast cancer 75
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 73
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 73
LUX-Lung 7: is there enough data for a final conclusion? 72
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analisys 72
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 71
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 71
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 70
Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: A detailed clinical, pathologic, and molecular characterization 68
Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020 66
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis 66
Diffuse liver infiltration by lobular breast carcinoma: Shear wave elastography as gold standard imaging study. 65
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 63
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 58
Bevacizumab-based neoadjuvant chemotherapy for colorectal cancer liver metastases: Pitfalls and helpful tricks in a review for clinicians 57
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 57
Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize Outcomes 57
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA 57
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial 55
Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2 52
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors 52
Usefulness of automated breast volume scanner (ABVS) for monitoring tumor response to neoadjuvant treatment in breast cancer patients: preliminary results 52
Association between background parenchymal enhancement and tumor response in patients with breast cancer receiving neoadjuvant chemotherapy 50
A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer 49
How will artificial intelligence impact breast cancer research efficiency? 47
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis 46
Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope 44
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 43
New life for retrospective study in the precision oncology era 41
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 39
Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting 38
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy 38
Definition of a tool to assess shared decision-making (SDM) on women with breast cancer: A value-based approach 38
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives 35
The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer 34
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 34
Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study 33
Targeted therapy in advanced gastric carcinoma: The future is beginning 31
To treat or no to treat: HER2 equivocal is the matter! 25
New challenges in multimodal workout of locally advanced breast cancer 20
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria 17
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 16
Automated breast volume scanner (ABVS) compared to handheld ultrasound (HHUS) and contrast-enhanced magnetic resonance imaging (CE-MRI) in the early assessment of breast cancer during neoadjuvant chemotherapy: an emerging role to monitoring tumor response? 14
Racial and ethnic disparities in breast cancer survival: critical appraisal of the data emerging from the randomized TAILORx 14
Long-Term Safety of Level II Oncoplastic Surgery after Neoadjuvant Treatment for Locally Advanced Breast Cancer: A 20-Year Experience 12
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study 12
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study 11
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials 11
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis 10
Baseline 18F-FDG PET/CT for predicting pathological response to neoadjuvant chemotherapy and prognosis in locally advanced breast cancer patients: analysis of tumor and lymphoid organs metabolic parameters 10
Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study 7
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study 7
Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response 6
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors 6
Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence 4
Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report 3
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 3
Demystifying BRAF Mutation Status in Colorectal Liver Metastases: A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions 3
BRAF in metastatic colorectal cancer: the future starts now 2
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 2
Totale 5.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.643
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.643
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 0 0 0 0 0 19
2020/2021417 13 27 14 44 93 32 47 4 42 30 49 22
2021/2022657 59 11 10 67 18 50 18 83 34 41 131 135
2022/20231.395 188 194 99 197 79 142 90 135 145 40 52 34
2023/2024748 40 164 30 34 38 151 53 43 16 19 75 85
2024/20251.650 37 28 135 59 134 51 69 57 203 312 540 25
Totale 5.775